The influence of ergotamine abuse on psychological and cognitive functioning

被引:10
|
作者
Roon, KI
Bakker, D
van Poelgeest, MIE
van Buchem, MA
Ferrari, MD
Middelkoop, HAM
机构
[1] Leiden Univ, Med Ctr, Dept Neurol J3R44, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Radiol, NL-2300 RC Leiden, Netherlands
关键词
ergotamine abuse; ergot headache; psychological distress; cognitive functioning; withdrawal;
D O I
10.1046/j.1468-2982.2000.00067.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Migraine patients abusing ergotamine often have chronic daily headaches associated with tiredness, sleep and memory disturbances, and reduced general well-being. We quantified psychological and cognitive functioning in 12 migraine patients with and 12 without ergotamine abuse (greater than or equal to 5 days/week for greater than or equal to 6 months) and 12 healthy controls. Psychological functioning assessed by Symptom Checklist-90 (SCL-90) and Profile Of Mood State (POMS), was impaired in ergotamine abusers compared to healthy controls. Cognitive functioning divided into four domains: attention (critical flicker frequency analysis and mental control subscale of the Wechsler Memory Scale (WMS), speed of information processing (reaction time tasks and lexical decision tasks), memory (four subscales of the WMS) and cognitive flexibility (trailmaking test and WMS digits backwards), was impaired in ergotamine abusers in speed of information processing and cognitive flexibility. These differences disappeared after correction for total SCL-90 scores. In conclusion, ergotamine abuse is associated with high psychological distress but not with structural impaired cognitive functioning.
引用
收藏
页码:462 / 469
页数:8
相关论文
共 50 条
  • [1] Psychological transition and adjustment processes related to retirement: influence on cognitive functioning
    Grotz, Catherine
    Matharan, Fanny
    Amieva, Helene
    Peres, Karine
    Laberon, Sonia
    Vonthron, Anne-Marie
    Dartigues, Jean-Francois
    Adam, Stephane
    Letenneur, Luc
    AGING & MENTAL HEALTH, 2017, 21 (12) : 1310 - 1316
  • [2] Substance abuse and cognitive functioning in schizophrenia
    Addington, J
    Addington, D
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1997, 22 (02): : 99 - 104
  • [3] Religious/Spiritual Abuse and Psychological and Spiritual Functioning
    Ellis, Heidi M.
    Hook, Joshua N.
    Freund, Caleb
    Kranendonk, Jacob
    Zuniga, Sabrina
    Davis, Don E.
    Van Tongeren, Daryl R.
    SPIRITUALITY IN CLINICAL PRACTICE, 2025, 12 (01) : 136 - 145
  • [4] Cognitive and Psychological Functioning in Fabry Disease
    Sigmundsdottir, Linda
    Tchan, Michel C.
    Knopman, Alex A.
    Menzies, Graham C.
    Batchelor, Jennifer
    Sillence, David O.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2014, 29 (07) : 642 - 650
  • [5] Executive cognitive functioning and risk for substance abuse
    Giancola, PR
    Tarter, RE
    PSYCHOLOGICAL SCIENCE, 1999, 10 (03) : 203 - 205
  • [6] Impact of drug abuse on cognitive functioning in schizophrenia
    Krysta, K
    Krupka-Matuszczyk, I
    Klasik, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S579 - S579
  • [7] TOLFENAMIC ACID AND ERGOTAMINE ABUSE
    ALAHURULA, V
    MYLLYLA, VV
    HOKKANEN, E
    TOKOLA, O
    HEADACHE, 1981, 21 (06): : 240 - 242
  • [8] The influence of multimorbidity on cognitive functioning
    Aarts S.
    Van Den Akker M.
    Tan F.
    Verhey F.
    Metsemakers J.
    Van Boxtel M.
    Huisarts en wetenschap, 2011, 54 (3) : 128 - 132
  • [9] Association of cognitive functioning, psychological traits and cognitive complaints in aging
    Slupczewski, Jakub
    Gut, Malgorzata
    Tarnowski, Adam
    INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2024, 59 : 153 - 154
  • [10] Psychological disturbance and cognitive functioning in TBI patients
    Udala, Megan
    Clark, Jeneya
    Miller, Harry
    Leitner, Damian
    Libben, Maya
    APPLIED NEUROPSYCHOLOGY-ADULT, 2019, 26 (06) : 581 - 590